Anti-malarial Drugs Market 2025 | Industry Developments, Future Growth, Share & Industry Insights | Novartis AG, Ipca Laboratories Ltd, Alvizia Health Care

Anti-malarial Drugs Market is expected to grow at a CAGR of 5% during the forecast period 2024-2031

DataM Intelligence unveils its latest report on the "Anti-malarial Drugs Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/anti-malarial-drugs-market?sg

List of Top Key Player: GlaxoSmithKline PLC, Cipla, Mylan N.V., F. Hoffmann-La Roche AG, Novartis AG, Ipca Laboratories Ltd. and Alvizia Health Care.

Industry Developments:

✅ 04-Mar-2025 - FDA placed a clinical hold on BioNTech's experimental malaria vaccine (BNT165e) pending safety data, pausing the U.S. trial.

✅ Aug-2025 - Japanese researchers presented new vaccine/drug advances at UTOPIA/TICAD-related meetings as Japan steps up malaria R&D and international collaboration.

✅ 10-Apr-2025 - South Korea reported ongoing malaria detections and rolled out its second Malaria Eradication Action Plan while domestic biopharma R&D investment rises.

✅ 08-Jul-2025 - Swissmedic approved Novartis's Coartem® (artemether-lumefantrine) Baby - the first malaria medicine for newborns/young infants - and Novartis affirmed continued production amid funding pressures.

✅ Takeda pledged to the Global Fund's 8th replenishment and renewed malaria commitments.
The move strengthens public-private funding partnerships for malaria R&D and access programs.

✅ Swissmedic approved Novartis's Coartem® Baby (artemether-lumefantrine) - first malaria treatment for newborns/young infants.
Novartis/Medicines for Malaria Venture plan nonprofit-focused distribution to endemic countries.

Forecast Projection:

The Global Anti-malarial Drugs Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Anti-malarial Drugs Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=anti-malarial-drugs-market?sg

Key Segmentation:

By Malaria Type (Plasmodium falciparum, Plasmodium malariae, Plasmodium vivax, Plasmodium ovale, Plasmodium knowlesi)

By Drug Class (Aminoquinolines (Chloroquine, HydroxyChloroquine, Primaquine, Tafenoquine, Others), Quinoline-methanol (4-quinolinemethanols, Others), Cinchona Alkaloids (Quinine, Quinidine), Biguanides (Proguanil, Chlorproguanil), Sulfonamides (Sulfadoxine, Dapsone, Others), Sulfones, Artemisinin Derivatives, Others)

By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Anti-malarial Drugs Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/anti-malarial-drugs-market?sg

FAQ's

Q1: How fast is the Anti-malarial Drugs Market expected to grow in the coming years?

A: Anti-malarial Drugs Market is expected to grow at a CAGR of 5% during the forecast period 2024-2031

Q2: Which regions are dominating the Anti-malarial Drugs Market and which are fastest-growing?

A: The Middle East & Africa region holds the largest market share in the global anti-malarial drugs market

Request 2 Days Free Trials with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.